Extended Data Table 1 Number of participants and timepoints per study in NO.MS and Roche MS

From: AI-driven reclassification of multiple sclerosis progression

  1. For NO.MS, all longitudinal data from the same participants in corresponding extension studies are also included in the analysis. For Roche MS, all longitudinal data from the same participants in corresponding extension studies were also included in the analysis for ORATORIO. For OPERA I and II, the Multiple Sclerosis Functional Composite (MSFC) with its components T25FWT, 9HPT and PASAT were collected only in the core study but not the extension studies. Therefore, only the core phase from OPERA I and II could be used for the validation.
Back to article page